Peter Byeff, MD

Cancer Center of Central Connecticut

Southington, Connecticut - 06489 (860-621-9316)

CLINICAL TRIALS 2
CONDITIONS6
INTERVENTIONS3
SINCE2008

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

January 2009 - June 2018

IGIV Study for Chronic ITP Patients Ages 3-70

February 2008 - March 2010

Leukemia

Leukemia, Lymphocytic, Chronic, B-Cell

Leukemia, Lymphoid

Purpura

Purpura, Thrombocytopenic

Purpura, Thrombocytopenic, Idiopathic

Placebo

Lenalidomide

Igiv3i Grifols 10%

Learn about TrialX Patient Recruitment services

Philip J. Stella, MD

Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center

Angela S. Kueck

Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center

John C. Krauss

Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center

Stephen Grund

Manchester Memorial Hospital

John R Saksa, PsyD

Yale University School of Medicine Yale University

Scott W Woods, MD

Yale University School of Medicine Yale University

Heidi L Grantz, LCSW

Yale University School of Medicine

Ralph E. Hoffman, MD

Yale Psychiatric Research Yale University School of Medicine

James F Leckman, MD

Yale University School of Medicine

Bradley F Peterson, MD

Yale University School of Medicine